Metraipolis › archive › dc_0ee27e4dd10e

Targeting CCR7-KMT2D enhances CAR-T cell efficacy by suppressing therapy-induced senescence in B-cell non-Hodgkin lymphoma — Europe PMC PMID:42363110

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/42363110
DOI
10.1186/s12916-[numero omesso]-4
License (as archived)
solo-consultazione
Archived
2026-10-18T19:07:58.332Z
SHA-256 of the archived text
5daaaec4a134ca9c0593855c5cf1bc18ac634153e703eb53cd938ab46a16fa8d
Stable URL of this page
https://metraipolis.com/documento/dc_0ee27e4dd10e

How to cite

Targeting CCR7-KMT2D enhances CAR-T cell efficacy by suppressing therapy-induced senescence in B-cell non-Hodgkin lymphoma — Europe PMC PMID:42363110 — Europe PMC (en), https://europepmc.org/article/MED/42363110 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_0ee27e4dd10e (Metraipolis archive dc_0ee27e4dd10e, sha256 5daaaec4a134ca9c0593855c5cf1bc18ac634153e703eb53cd938ab46a16fa8d)
BibTeX
@misc{dc0ee27e4dd10e,
  title = {Targeting CCR7-KMT2D enhances CAR-T cell efficacy by suppressing therapy-induced senescence in B-cell non-Hodgkin lymphoma — Europe PMC PMID:42363110},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/42363110},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_0ee27e4dd10e; sha256 5daaaec4a134ca9c0593855c5cf1bc18ac634153e703eb53cd938ab46a16fa8d},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42363110. Agents can read the archived copy with the MCP tool read_document.